1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Dermatophytic Onychomycosis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Oral Medicine 1.2.3 External Medicine 1.3 Market by Application 1.3.1 Global Dermatophytic Onychomycosis Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Age Under 18 1.3.3 Age 18-50 1.3.4 Age Above 50 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Dermatophytic Onychomycosis Market Perspective (2017-2028) 2.2 Dermatophytic Onychomycosis Growth Trends by Region 2.2.1 Dermatophytic Onychomycosis Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Dermatophytic Onychomycosis Historic Market Size by Region (2017-2022) 2.2.3 Dermatophytic Onychomycosis Forecasted Market Size by Region (2023-2028) 2.3 Dermatophytic Onychomycosis Market Dynamics 2.3.1 Dermatophytic Onychomycosis Industry Trends 2.3.2 Dermatophytic Onychomycosis Market Drivers 2.3.3 Dermatophytic Onychomycosis Market Challenges 2.3.4 Dermatophytic Onychomycosis Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Dermatophytic Onychomycosis Players by Revenue 3.1.1 Global Top Dermatophytic Onychomycosis Players by Revenue (2017-2022) 3.1.2 Global Dermatophytic Onychomycosis Revenue Market Share by Players (2017-2022) 3.2 Global Dermatophytic Onychomycosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Dermatophytic Onychomycosis Revenue 3.4 Global Dermatophytic Onychomycosis Market Concentration Ratio 3.4.1 Global Dermatophytic Onychomycosis Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Dermatophytic Onychomycosis Revenue in 2021 3.5 Dermatophytic Onychomycosis Key Players Head office and Area Served 3.6 Key Players Dermatophytic Onychomycosis Product Solution and Service 3.7 Date of Enter into Dermatophytic Onychomycosis Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Dermatophytic Onychomycosis Breakdown Data by Type 4.1 Global Dermatophytic Onychomycosis Historic Market Size by Type (2017-2022) 4.2 Global Dermatophytic Onychomycosis Forecasted Market Size by Type (2023-2028) 5 Dermatophytic Onychomycosis Breakdown Data by Application 5.1 Global Dermatophytic Onychomycosis Historic Market Size by Application (2017-2022) 5.2 Global Dermatophytic Onychomycosis Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Dermatophytic Onychomycosis Market Size (2017-2028) 6.2 North America Dermatophytic Onychomycosis Market Size by Country (2017-2022) 6.3 North America Dermatophytic Onychomycosis Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Dermatophytic Onychomycosis Market Size (2017-2028) 7.2 Europe Dermatophytic Onychomycosis Market Size by Country (2017-2022) 7.3 Europe Dermatophytic Onychomycosis Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Dermatophytic Onychomycosis Market Size (2017-2028) 8.2 Asia-Pacific Dermatophytic Onychomycosis Market Size by Country (2017-2022) 8.3 Asia-Pacific Dermatophytic Onychomycosis Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Dermatophytic Onychomycosis Market Size (2017-2028) 9.2 Latin America Dermatophytic Onychomycosis Market Size by Country (2017-2022) 9.3 Latin America Dermatophytic Onychomycosis Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Dermatophytic Onychomycosis Market Size (2017-2028) 10.2 Middle East & Africa Dermatophytic Onychomycosis Market Size by Country (2017-2022) 10.3 Middle East & Africa Dermatophytic Onychomycosis Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Johnson & Johnson 11.1.1 Johnson & Johnson Company Detail 11.1.2 Johnson & Johnson Business Overview 11.1.3 Johnson & Johnson Dermatophytic Onychomycosis Introduction 11.1.4 Johnson & Johnson Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.1.5 Johnson & Johnson Recent Development 11.2 GSK 11.2.1 GSK Company Detail 11.2.2 GSK Business Overview 11.2.3 GSK Dermatophytic Onychomycosis Introduction 11.2.4 GSK Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.2.5 GSK Recent Development 11.3 Novartis 11.3.1 Novartis Company Detail 11.3.2 Novartis Business Overview 11.3.3 Novartis Dermatophytic Onychomycosis Introduction 11.3.4 Novartis Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.3.5 Novartis Recent Development 11.4 Pfizer 11.4.1 Pfizer Company Detail 11.4.2 Pfizer Business Overview 11.4.3 Pfizer Dermatophytic Onychomycosis Introduction 11.4.4 Pfizer Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.4.5 Pfizer Recent Development 11.5 Bausch Health 11.5.1 Bausch Health Company Detail 11.5.2 Bausch Health Business Overview 11.5.3 Bausch Health Dermatophytic Onychomycosis Introduction 11.5.4 Bausch Health Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.5.5 Bausch Health Recent Development 11.6 Kaken Pharmaceutical 11.6.1 Kaken Pharmaceutical Company Detail 11.6.2 Kaken Pharmaceutical Business Overview 11.6.3 Kaken Pharmaceutical Dermatophytic Onychomycosis Introduction 11.6.4 Kaken Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.6.5 Kaken Pharmaceutical Recent Development 11.7 Galderma 11.7.1 Galderma Company Detail 11.7.2 Galderma Business Overview 11.7.3 Galderma Dermatophytic Onychomycosis Introduction 11.7.4 Galderma Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.7.5 Galderma Recent Development 11.8 Sanofi 11.8.1 Sanofi Company Detail 11.8.2 Sanofi Business Overview 11.8.3 Sanofi Dermatophytic Onychomycosis Introduction 11.8.4 Sanofi Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.8.5 Sanofi Recent Development 11.9 Allergan 11.9.1 Allergan Company Detail 11.9.2 Allergan Business Overview 11.9.3 Allergan Dermatophytic Onychomycosis Introduction 11.9.4 Allergan Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.9.5 Allergan Recent Development 11.10 Merz Pharma 11.10.1 Merz Pharma Company Detail 11.10.2 Merz Pharma Business Overview 11.10.3 Merz Pharma Dermatophytic Onychomycosis Introduction 11.10.4 Merz Pharma Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.10.5 Merz Pharma Recent Development 11.11 Xiuzheng Pharmaceutical 11.11.1 Xiuzheng Pharmaceutical Company Detail 11.11.2 Xiuzheng Pharmaceutical Business Overview 11.11.3 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Introduction 11.11.4 Xiuzheng Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.11.5 Xiuzheng Pharmaceutical Recent Development 11.12 Letai 11.12.1 Letai Company Detail 11.12.2 Letai Business Overview 11.12.3 Letai Dermatophytic Onychomycosis Introduction 11.12.4 Letai Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.12.5 Letai Recent Development 11.13 Qilu Pharmaceutical 11.13.1 Qilu Pharmaceutical Company Detail 11.13.2 Qilu Pharmaceutical Business Overview 11.13.3 Qilu Pharmaceutical Dermatophytic Onychomycosis Introduction 11.13.4 Qilu Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2017-2022) 11.13.5 Qilu Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Dermatophytic Onychomycosis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Oral Medicine Table 3. Key Players of External Medicine Table 4. Global Dermatophytic Onychomycosis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Dermatophytic Onychomycosis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Dermatophytic Onychomycosis Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Dermatophytic Onychomycosis Market Share by Region (2017-2022) Table 8. Global Dermatophytic Onychomycosis Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Dermatophytic Onychomycosis Market Share by Region (2023-2028) Table 10. Dermatophytic Onychomycosis Market Trends Table 11. Dermatophytic Onychomycosis Market Drivers Table 12. Dermatophytic Onychomycosis Market Challenges Table 13. Dermatophytic Onychomycosis Market Restraints Table 14. Global Dermatophytic Onychomycosis Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Dermatophytic Onychomycosis Market Share by Players (2017-2022) Table 16. Global Top Dermatophytic Onychomycosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatophytic Onychomycosis as of 2021) Table 17. Ranking of Global Top Dermatophytic Onychomycosis Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Dermatophytic Onychomycosis Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Dermatophytic Onychomycosis Product Solution and Service Table 21. Date of Enter into Dermatophytic Onychomycosis Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Dermatophytic Onychomycosis Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Dermatophytic Onychomycosis Revenue Market Share by Type (2017-2022) Table 25. Global Dermatophytic Onychomycosis Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Dermatophytic Onychomycosis Revenue Market Share by Type (2023-2028) Table 27. Global Dermatophytic Onychomycosis Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Dermatophytic Onychomycosis Revenue Market Share by Application (2017-2022) Table 29. Global Dermatophytic Onychomycosis Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Dermatophytic Onychomycosis Revenue Market Share by Application (2023-2028) Table 31. North America Dermatophytic Onychomycosis Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Dermatophytic Onychomycosis Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Dermatophytic Onychomycosis Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Dermatophytic Onychomycosis Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Dermatophytic Onychomycosis Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Dermatophytic Onychomycosis Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Dermatophytic Onychomycosis Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Dermatophytic Onychomycosis Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Dermatophytic Onychomycosis Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Dermatophytic Onychomycosis Market Size by Country (2023-2028) & (US$ Million) Table 41. Johnson & Johnson Company Detail Table 42. Johnson & Johnson Business Overview Table 43. Johnson & Johnson Dermatophytic Onychomycosis Product Table 44. Johnson & Johnson Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 45. Johnson & Johnson Recent Development Table 46. GSK Company Detail Table 47. GSK Business Overview Table 48. GSK Dermatophytic Onychomycosis Product Table 49. GSK Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 50. GSK Recent Development Table 51. Novartis Company Detail Table 52. Novartis Business Overview Table 53. Novartis Dermatophytic Onychomycosis Product Table 54. Novartis Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 55. Novartis Recent Development Table 56. Pfizer Company Detail Table 57. Pfizer Business Overview Table 58. Pfizer Dermatophytic Onychomycosis Product Table 59. Pfizer Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 60. Pfizer Recent Development Table 61. Bausch Health Company Detail Table 62. Bausch Health Business Overview Table 63. Bausch Health Dermatophytic Onychomycosis Product Table 64. Bausch Health Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 65. Bausch Health Recent Development Table 66. Kaken Pharmaceutical Company Detail Table 67. Kaken Pharmaceutical Business Overview Table 68. Kaken Pharmaceutical Dermatophytic Onychomycosis Product Table 69. Kaken Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 70. Kaken Pharmaceutical Recent Development Table 71. Galderma Company Detail Table 72. Galderma Business Overview Table 73. Galderma Dermatophytic Onychomycosis Product Table 74. Galderma Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 75. Galderma Recent Development Table 76. Sanofi Company Detail Table 77. Sanofi Business Overview Table 78. Sanofi Dermatophytic Onychomycosis Product Table 79. Sanofi Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 80. Sanofi Recent Development Table 81. Allergan Company Detail Table 82. Allergan Business Overview Table 83. Allergan Dermatophytic Onychomycosis Product Table 84. Allergan Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 85. Allergan Recent Development Table 86. Merz Pharma Company Detail Table 87. Merz Pharma Business Overview Table 88. Merz Pharma Dermatophytic Onychomycosis Product Table 89. Merz Pharma Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 90. Merz Pharma Recent Development Table 91. Xiuzheng Pharmaceutical Company Detail Table 92. Xiuzheng Pharmaceutical Business Overview Table 93. Xiuzheng Pharmaceutical Dermatophytic OnychomycosisProduct Table 94. Xiuzheng Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 95. Xiuzheng Pharmaceutical Recent Development Table 96. Letai Company Detail Table 97. Letai Business Overview Table 98. Letai Dermatophytic OnychomycosisProduct Table 99. Letai Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 100. Letai Recent Development Table 101. Qilu Pharmaceutical Company Detail Table 102. Qilu Pharmaceutical Business Overview Table 103. Qilu Pharmaceutical Dermatophytic OnychomycosisProduct Table 104. Qilu Pharmaceutical Revenue in Dermatophytic Onychomycosis Business (2017-2022) & (US$ Million) Table 105. Qilu Pharmaceutical Recent Development Table 106. Research Programs/Design for This Report Table 107. Key Data Information from Secondary Sources Table 108. Key Data Information from Primary Sources List of Figures Figure 1. Global Dermatophytic Onychomycosis Market Share by Type: 2021 VS 2028 Figure 2. Oral Medicine Features Figure 3. External Medicine Features Figure 4. Global Dermatophytic Onychomycosis Market Share by Application in 2021 & 2028 Figure 5. Age Under 18 Case Studies Figure 6. Age 18-50 Case Studies Figure 7. Age Above 50 Case Studies Figure 8. Dermatophytic Onychomycosis Report Years Considered Figure 9. Global Dermatophytic Onychomycosis Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Dermatophytic Onychomycosis Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Dermatophytic Onychomycosis Market Share by Region: 2021 VS 2028 Figure 12. Global Dermatophytic Onychomycosis Market Share by Players in 2021 Figure 13. Global Top Dermatophytic Onychomycosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatophytic Onychomycosis as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Dermatophytic Onychomycosis Revenue in 2021 Figure 15. North America Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Dermatophytic Onychomycosis Market Share by Country (2017-2028) Figure 17. United States Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Dermatophytic Onychomycosis Market Share by Country (2017-2028) Figure 21. Germany Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Dermatophytic Onychomycosis Market Share by Region (2017-2028) Figure 29. China Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Dermatophytic Onychomycosis Market Share by Country (2017-2028) Figure 37. Mexico Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Dermatophytic Onychomycosis Market Share by Country (2017-2028) Figure 41. Turkey Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Dermatophytic Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Johnson & Johnson Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 44. GSK Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 45. Novartis Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 46. Pfizer Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 47. Bausch Health Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 48. Kaken Pharmaceutical Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 49. Galderma Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 50. Sanofi Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 51. Allergan Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 52. Merz Pharma Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 53. Xiuzheng Pharmaceutical Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 54. Letai Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 55. Qilu Pharmaceutical Revenue Growth Rate in Dermatophytic Onychomycosis Business (2017-2022) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Johnson & Johnson GSK Novartis Pfizer Bausch Health Kaken Pharmaceutical Galderma Sanofi Allergan Merz Pharma Xiuzheng Pharmaceutical Letai Qilu Pharmaceutical